How breast cancer treatment changes metabolism and bone
Part of Heart & circulation, Hormones & metabolism, Injuries & trauma clinical trials.
This study looks at how standard breast cancer treatments affect your body’s metabolism and bones in postmenopausal people with early-stage breast cancer. It may help doctors better predict and prevent bone and metabolic side effects from treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have gone through menopause
- Your breast cancer is stage I, II, or III (not metastatic)
- Your cancer is planned to be treated with chemotherapy or another cancer medicine (as adjuvant or neoadjuvant treatment)
- You have not had another past cancer diagnosis before
- You do not have certain metabolic diseases, such as diabetes
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how early hormone therapy affects metabolism in women with ER+ breast cancer. It aims to understand changes in blood sugar, fat, and weight, which could help doctors support your health during treatment.
This study looks at how well your body uses insulin (a hormone that helps move sugar from the blood into cells) after breast cancer treatment. It may help researchers understand whether insulin sensitivity changes after chemotherapy and could guide future health monitoring.
This study looks at how your metabolism (things like blood sugar and cholesterol) might be linked to tumor genes and growth in people with breast cancer. The goal is to find new ways to treat the disease based on your metabolic profile. You may be eligible if you have locally advanced breast cancer (Stage II–III) and are willing to share your medical records.
This study follows how “metabolic health” patterns (like eating timing and daily activity) change over time during breast cancer care. It may help researchers learn which habit patterns are linked to better outcomes and comfort during chemotherapy.
This study looks at how the body's metabolism changes in women with suspected or confirmed ovarian cancer. Researchers will follow participants before and after surgery and chemotherapy to better understand whole-body energy use.
This study tests if metformin, a common diabetes medicine, can help reduce insulin resistance in women who finished chemotherapy for early-stage breast cancer. It aims to improve long-term health and prevent future problems.
Hear when a new Insulin Resistance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.